Bryostatins
   HOME
*



picture info

Bryostatins
Bryostatins are a group of macrolide lactones from the marine organism ''Bugula neritina'' that were first collected and provided to JL Hartwell’s anticancer drug discovery group at the National Cancer Institute (NCI) by Jack Rudloe. Bryostatins are potent modulators of protein kinase C. They have been studied in clinical trials as anti-cancer agents, as anti-AIDS/HIV agents and in people with Alzheimer's disease. Biological effects Bryostatin 1 is a potent modulator of protein kinase C (PKC). It showed activity in laboratory tests in cells and model animals, so it was brought into clinical trials. As of 2014 over thirty clinical trials had been conducted, using bryostatin alone and in combination with other agents, in both solid tumors and blood tumors; it did not show a good enough risk:benefit ratio to be advanced further. It showed enough promise in animal models of Alzheimer's disease that a Phase II trial was started by 2010; the trial was sponsored by the Blanchett ...
[...More Info...]      
[...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]  




Bryostatin Biosynthetic Diagram
Bryostatins are a group of macrolide lactones from the marine organism ''Bugula neritina'' that were first collected and provided to JL Hartwell’s anticancer drug discovery group at the National Cancer Institute (NCI) by Jack Rudloe. Bryostatins are potent modulators of protein kinase C. They have been studied in clinical trials as anti-cancer agents, as anti-AIDS/HIV agents and in people with Alzheimer's disease. Biological effects Bryostatin 1 is a potent modulator of protein kinase C (PKC). It showed activity in laboratory tests in cells and model animals, so it was brought into clinical trials. As of 2014 over thirty clinical trials had been conducted, using bryostatin alone and in combination with other agents, in both solid tumors and blood tumors; it did not show a good enough risk:benefit ratio to be advanced further. It showed enough promise in animal models of Alzheimer's disease that a Phase II trial was started by 2010; the trial was sponsored by the Blanchett ...
[...More Info...]      
[...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]  



MORE